| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| EPS HOLDINGS Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 18,860 | -1,77 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| PROGYNY | 17,800 | +1,60 % | INVO Fertility, Inc.: INVO Fertility's Wisconsin Clinic Joins Progyny Network | ||
| PROCEPT BIOROBOTICS | 26,600 | +2,62 % | Truist cuts Procept BioRobotics stock price target on lower forecasts | ||
| LIFESTANCE HEALTH GROUP | 7,325 | +2,45 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| HEARTFLOW | 23,910 | +2,44 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| INNOVAGE | 10,610 | +14,46 % | InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2025 | DENVER, Feb. 03, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly... ► Artikel lesen | |
| NEUROPACE | 13,960 | -1,34 % | Why NeuroPace Stock Was Inching Higher on Wednesday | ||
| PRIVIA HEALTH GROUP | 24,310 | +1,21 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen | |
| BETA BIONICS | 11,380 | -6,80 % | Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| TALKSPACE | 4,930 | +1,75 % | Talkspace Announces Fourth Quarter and Full Year 2025 Results | 4Q 2025 total revenue grew 29% year-over-year to $63.0 million4Q 2025 net income of $4.8 million and adjusted EBITDA1 of $6.6 million Full-year 2025 total revenue grew 22% year-over-year to $228.9... ► Artikel lesen | |
| ADAPTHEALTH | 9,670 | +0,36 % | Leerink cuts AdaptHealth stock price target on 2025 earnings decline | ||
| AVEANNA HEALTHCARE | 7,410 | -0,27 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance | ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| LUMEXA IMAGING | 15,520 | -2,14 % | Lumexa Imaging Holdings, Inc. - 8-K, Current Report | ||
| CONCENTRA GROUP | 23,560 | -0,72 % | Concentra outlines $2.25B-$2.35B 2026 revenue target while expanding de novo and M&A strategy | ||
| GUARDIAN PHARMACY SERVICES | 34,740 | +3,24 % | Guardian Pharmacy Services stock price target raised to $36 at Stephens |